Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-12-19 Sale | 2024-12-20 4:21 pm | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 1,118 | $8 | $8,944 | 1,028,582 (Indirect Direct) | View |
| 2024-12-19 Sale | 2024-12-20 4:20 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 1,291 | $8 | $10,328 | 100,067 (Indirect Direct) | View |
| 2024-12-13 Purchase | 2024-12-16 08:05 am | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 12,500 | $7.9267 | $99,084 | 57,000 (Direct) | View |
| 2024-12-13 Purchase | 2024-12-16 08:05 am | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 10,000 | $8.1248 | $81,248 | 75,500 (Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:52 pm | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 10,901 | $11.72 | $127,760 | 1,029,700 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:51 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 4,325 | $11.72 | $50,689 | 101,358 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:50 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 33,848 | $11.72 | $396,699 | 381,574 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 4:30 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 3,435 | $11.1 | $38,129 | 97,174 (Indirect Direct) | View |
| 2024-03-22 Sale | 2024-03-26 4:05 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 16,851 | $9.11 | $153,513 | 414,624 (Indirect Direct) | View |
| 2024-01-24 Sale | 2024-01-25 06:13 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 3,703,703 | $8.1 | $29,999,994 | 3,755,583 (Direct) | View |
| 2024-01-19 Sale | 2024-01-22 8:22 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 6,307 | $7.7533 | $48,900 | 220,609 (Indirect Direct) | View |
| 2023-11-20 Sale | 2023-11-21 4:40 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 2,127 | $7.2415 | $15,403 | 104,195 (Indirect Direct) | View |
| 2023-11-06 Purchase | 2023-11-08 7:56 pm | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 7,500 | $7.8107 | $58,580 | 55,000 (Direct) | View |
| 2023-11-01 Sale | 2023-11-03 4:55 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 12,492 | $8.8753 | $110,871 | 106,322 (Indirect Direct) | View |
| 2023-06-02 Sale | 2023-06-05 6:32 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 1,960 | $11.41 | $22,368 | 68,845 (Indirect Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-05-31 Option Award | 2024-05-31 6:37 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 7,500 | $0 | 104,674 (Direct) | View |
| 2024-05-31 Option Award | 2024-05-31 6:34 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 7,500 | $0 | 1,038,846 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 25,000 | $10.16 | 44,500 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:47 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director 10% Owner | 28,000 | $0 | 5,880,924 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:46 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 28,000 | $0 | 83,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:44 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | COLA MICHAEL F Director | 28,000 | $0 | 46,798 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:43 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:33 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:18 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:14 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director | 28,000 | $0 | 1,248,756 (Direct) | View |
Ownership | 2024-01-26 4:35 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I GP Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi IV GP Ltd Medicxi IV LP Medicxi Co-Invest IV LP 10% Owner | 0 | $0 | 7,464,572 (Indirect) | View |
| 2024-01-18 Option Award | 2024-01-22 8:22 pm | N/A 2034-01-17 | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 120,000 | $0 | 220,609 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 8:21 pm | N/A 2034-01-17 | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 130,000 | $0 | 130,000 (Direct) | View |
| 2024-01-18 Option Award | 2024-01-22 8:19 pm | N/A 2034-01-17 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 475,000 | $0 | 475,000 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 4:55 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 22,500 | $0 | 106,322 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 4:54 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 32,500 | $0 | 1,031,346 (Direct) | View |
| 2023-11-01 Option Award | 2023-11-03 4:53 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 37,500 | $0 | 430,751 (Direct) | View |
| 2023-07-14 Option Award(A) | 2023-07-21 8:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 25,000 | $0 | 95,180 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:00 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 25,000 | $1 | 96,314 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:00 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 200,000 | $0 | 393,251 (Direct) | View |
| 2023-07-14 Disposition | 2023-07-17 5:00 pm | N/A 2030-06-30 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 400,000 | $0 | 393,251 (Direct) | View |
| 2023-07-14 Option Award | 2023-07-17 5:00 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 110,000 | $0 | 998,846 (Direct) | View |
| 2023-07-14 Disposition | 2023-07-17 5:00 pm | N/A 2030-06-30 | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 220,000 | $0 | 998,846 (Direct) | View |
| 2023-06-02 Option Award | 2023-06-05 6:37 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 15,000 | $7.4 | 47,500 (Direct) | View |
| 2023-06-02 Disposition | 2023-06-05 6:37 pm | N/A 2032-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 15,000 | $0 | 47,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 7:03 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director 10% Owner | 24,000 | $0 | 5,867,924 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 7:01 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 24,000 | $0 | 24,000 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 6:57 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director | 24,000 | $0 | 1,235,756 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 6:55 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 24,000 | $0 | 47,500 (Direct) | View |
| 2023-05-25 Option Award | 2023-05-30 6:53 pm | N/A 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director | 24,000 | $0 | 24,000 (Direct) | View |